Closing the IV Access Gap: The Case for Autonomous IV Cannulation

Peripheral IV cannulation is one of the most frequently performed procedures in clinical care. It is also one of the most skill-dependent. A successful placement requires extensive training, real-time judgment and a margin for error measured in millimeters.

As the nursing workforce faces mounting pressure and more care moves out of the hospital and into homes, communities and remote environments, the gap between patient need and the availability of trained nurses is widening. The question the healthcare system is beginning to confront is what happens when the skilled hands aren't there.

Autonomous IV cannulation—the ability of a device to locate a vein, insert a catheter and confirm placement without direct clinician intervention—is emerging as one potential answer to that question.

More Patients, Fewer Hands

IV placement is one of the most routine procedures in healthcare, and one of the most demanding on the nurses who perform it. Peripheral IV cannulation is performed more than a billion times annually worldwide, across emergency departments, surgical suites, infusion centers, oncology clinics and inpatient wards. Every placement requires real-time judgment and precise technique. In difficult cases, repeated attempts may be needed, consuming time and eroding patient comfort.

At the same time, the nursing workforce is under pressure that shows no sign of easing. The National Center for Health Workforce Analysis projects a shortage of more than 250,000 registered nurses by 2030 as skilled nurses retire or leave the workforce and the training pipeline lags behind demand. For a procedure as skill-dependent and as frequently required as IV cannulation, that shortfall has direct consequences in delayed treatment, strained staff and patient access.

That pressure is felt most acutely as care moves into settings where trained clinical support is harder to deliver: home infusion, community care, and emergency and military environments where IV access may be needed but a skilled practitioner may not be available. More than 4.2 million Americans now receive home-based infusion services annually, and that number is growing as payers and health systems push complex therapies into lower-cost and less restrictive settings. Hospital-at-home programs and community-based care programs for patients needing IV therapies depend on reliable vein access. In remote emergency, military and mass casualty settings, the stakes are higher still; IV access is often the first link in a chain of interventions that determines whether a patient survives.

The clinician gap is not just about numbers. It is about where skilled practitioners are, when they are available and what happens when they are not.

Why IV Placement Has Resisted Automation

Watch an experienced nurse place an IV and the procedure looks almost effortless. What's less visible is the continuous stream of judgment calls happening in real time: reading the vein through skin and tissue, adjusting angle and depth in response to subtle resistance, sensing the moment of entry and responding to shifts in patient position. It is a skill that can take years to fully develop and that draws on tactile feedback, pattern recognition and clinical intuition that are genuinely difficult to replicate in a device.

That is the core challenge of autonomous IV cannulation. Veins vary enormously from patient to patient in depth, diameter, fragility and visibility. The margin for error is measured in millimeters. And the insertion sequence (locating the vein, entering at the correct angle, confirming placement, advancing the catheter) must adapt continuously to what the device finds, not execute a fixed set of movements.

Existing assistive tools like near-infrared vein viewers and portable ultrasound can help a clinician find a vein. But the decision-making still belongs to the person holding the needle.

Replicating that judgment in a device—one that must perform reliably across the full range of human anatomy, in uncontrolled environments, without clinical oversight—is what makes autonomous cannulation a hard engineering problem.

Building Toward Autonomous IV Cannulation

Solving the autonomous cannulation challenge would meaningfully expand where reliable IV access can be delivered: to patients managing chronic conditions at home, to hospital-at-home programs operating without on-call nursing staff, to medics in the field establishing access under conditions that make even routine procedures difficult.

Three core engineering capabilities must come together to make it possible:

• Sensing: In order to guide insertion, the device needs to locate and map a suitable vein with enough precision to guide a needle accurately. Near-infrared imaging can visualize surface vein networks in real time by detecting the differential absorption of infrared light by deoxygenated hemoglobin; ultrasound provides a deeper view of vessel walls and can confirm needle position during insertion. A functional system will likely depend on both.
• Mechanical guidance: Imaging data is only useful if it can drive precise physical action. The device must position and advance a needle with controlled force and angle, respond to tissue resistance in real time, and complete the catheter deployment sequence, all within the anatomical variability of real patients and in a form factor compact enough to wear on the arm.
• Adaptive intelligence: The system cannot run on a fixed script. Onboard software must interpret sensor data continuously, make placement decisions and adjust in real time to what it encounters during insertion, including detecting the moment of vein entry and stopping the needle before it passes through the far wall.

What makes autonomous cannulation particularly demanding is that these capabilities must function as an integrated system, without clinical oversight, at the reliability and safety standard that medical device use requires.

That systems-level integration challenge is where Battelle's multidisciplinary teams are focused. Drawing on deep capabilities in sensor technology, mechanical engineering, software development and data science, Battelle engineers are developing a hardware prototype designed to demonstrate the core capabilities the system requires. The goals is to demonstrate that the core sensing, guidance and insertion capabilities can function as a reliable integrated system. This is a foundational step toward an autonomous IV cannulation device suitable for real-world use.

The goal is a device that extends reliable vein access to the patients and settings that need it most—not as a replacement for clinical judgment, but as an expansion of clinical reach. For the millions of patients who depend on regular IV access, and the healthcare systems working to deliver it consistently, that expansion represents a meaningful shift in what care can look like.

To learn more about Battelle's medical sensor and medical device capabilities, connect with our team.